re: ANX's Presentation at the Bio CEO & Investors Conference:

After watching ANX's presentation a couple of times yesterday, these are my impressions.

First, CEO Culley said that they should hear from the FDA about their decision to accept or deny the NDA for ANX-530 "in the next two weeks or so". This is something we all knew already, because the NDA was submitted in the final days of December 2009. The FDA has 60 days to make it's decision to accept, ask for more data (which means a long delay), or outright reject the NDA.

That gives the FDA until the last week of February or the first week of March to give ANX their decision on the NDA. I've been following small cap and micro cap biotech companies for about two years, and in all that time I've never seen the FDA render a decision early. So the best we can hope for is for the company to get their decision around the first of March, and to release a Press Release soon thereafter.

Yesterday's presentation was nearly a carbon copy of the presentation they made at the OneMedForum conference in San Francisco on December 15th 2009. The slide show was exactly the same, and the CEO's speech was almost identical. There were no new developments mentioned that we weren't already aware of. It was a very good presentation though, and I really like Mr. Culley's enthusiasm and speaking style.

The purpose of these types of conferences is to inform investors of what the company is all about, and to hopefully get them to invest in the company. I hope that Mr. Culley was successful in doing just that.

If you would like to listen to the presentation, here is a link to go to the webcast:

http://ir.adventrx.com/phoenix.zhtml?c=75414&p=irol-IRHome

Here is a post I made last night on the ANX Board at the InvestorsHub.com (IHUB) site:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46474923

It is an analysis of ANX's daily chart using a number of Technical Indicators.

Happy Trading!,
zigzagman

ADVENTRX Pharmaceuticals Inc. Presents At The 12th Annual Bio CEO & Investors Conference Today:

ANX is one of my favorite small cap BioTech stocks at the moment.

It is listed on the AMEX exchange, and is currently trading at around $0.30 per share. It has been a Volume Leader on the AMEX for two months or so. Here is a link to the company's website:

http://www.adventrx.com/

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer. The Company seeks to improve the performance and commercial potential of existing treatments by addressing problems associated with these treatment regimens.

ADVENTRX is presenting at the 12th Annual Biotechnology Industry Organization CEO & Investor Conference. Here is a list of all of the companies presenting at the conference. I have been following many of them for over a year:

http://ceo.bio.org/opencms/ceo/2010/Companies/PresentingCompanies.html

Here is the link to listen to the webcast live at 10:30am ET, or you can listen to it later:

http://ir.adventrx.com/phoenix.zhtml?c=75414&p=irol-IRHome

I don't expect any new news to be presented at this conference, because SEC Regulations require that a press release of any material event must be published to the entire world and not just to the participants of a conference.

But they may surprise us on this, because some types of developments don't require a press release. The best news they could give us today would be to name a target date for submitting a new drug application (NDA) for the second drug in their pipeline ANX-514.

There have also been buy out rumors spread all over the internet about this company over the past two months, but I don't think this has a possibility of happening until after the FDA approves the NDA for their first drug candidate ANX-530. ANX submitted a NDA to the FDA for this drug the last week of December 2009, and the FDA has sixty days to rule if they will accept or decline this NDA or not. We should hear news on this during the last week of February, or during the first week of March.

There are also talks of partnerships with one or more of the big BioTech companies. One of the purposes of a conference like today's is to have private meetings with the CEO's of the presenting companies. News of either a buy out or a partnership would surely be good news for this company, and it should reflect well on their share price.

I will be watching for unusual volume and price action on ANX today and the rest of this week. I will post my thoughts about their presentation later today. ANX is one of the few stocks that I am an "investor" in. I also have another block of shares that I trade in and out with using my day trading account.

Happy Trading,
zigzagman

Examples Of Real Trades That I Have Done:

To show you the kind of money you can make Day Trading, here are a few examples of real trades I have done:

On May 28th 2009 I made $1750. in only ten minutes of trading on two scalping trades on FAS:

I put $92,100. to work and made almost $900.00 in just under six minutes on this trade:

I put $93,000. to work and made just over $850.00 in exactly four minutes on this trade:



**************************************************************

I put $21,000. to work when I bought 2000 shares of TSO and made $280. in just three minutes!



**************************************************************

Here is another example of a ten minute Day Trade that made $300.00



**************************************************************

Here is another example of a seventeen minute Day Trade that made $300.00



**************************************************************

Here is another example of an eight minute Day Trade that also made $280.00



**************************************************************

As you can see, Day Trading is a very profitable way to trade the market in a very short period of time. I usually do two or three trades before lunchtime, and call it a day. A few hundred dollars a day is more than enough for my family to get by on comfortably. A full-time experienced Day Trader can easily gross $100,000. per year or more.

But don't think you can do this without proper training, because you can lose as much money on each trade shown above in a very short amount of time. Like anything worthwhile in life, you must get educated and pay your dues before you become truly successful.

I can show you how to make this kind of money in a much shorter amount of time than it took me to learn how to do it. You get my fifteen years of experience to show you the best way to Day Trade, without having to make the same mistakes I made when I first began trading.

Happy Trading,
zigzagman

**************************************************************